StockData
Sana Biotechnology, Inc. logo

Sana Biotechnology, Inc. (SANA) stock

SANANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$1.59−0.15 (-8.62%)

Close on Nov 20, 2026Market cap $475.98MP/E –Yield –

Sana Biotechnology revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Sana Biotechnology

Sana Biotechnology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Sana Biotechnology figures

See a number that looks wrong?